智慧藥丸技術市場規模、佔有率和成長分析（按目標領域、適用疾病、應用、最終用戶和地區）：產業預測（2025-2032）

2023年全球智慧藥丸技術市場規模為39億美元，從2024年的42.3億美元成長到2032年的81.3億美元，預測期（2025-2032）預計複合年成長率將達到8.5%。

智慧藥丸是數位健康領域的重要進步，具有膠囊式設計和檢測、成像和標靶藥物傳輸等先進功能。這些創新設備可透過胃腸道取得先前難以取得的診斷影像，有效地作為內視鏡檢查等傳統方法的非侵入性替代方法。智慧藥丸通常與穿戴式感測器貼片整合，通訊，使醫療保健專業人員能夠密切監控患者資料。它有助於診斷胃輕癱和便秘等胃腸道疾病，並提高用藥依從性。此系統可捕捉脈搏、體溫、胃酸鹼度等重要指標，全面了解患者的健康狀況，徹底改變胃腸疾病的診斷和治療方法。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

全球智慧藥丸技術市場規模與複合年成長率：依目標領域（2025-2032）

• 市場概況
• 食道
• 胃
• 小腸
• 冒號

全球智慧藥丸技術市場規模及複合年成長率：依適用疾病分類（2025-2032）

• 市場概況
• 巴瑞特氏食道症
• 小腸疾病
• 大腸直腸癌
• 其他

全球智慧藥丸技術市場規模與複合年成長率：按應用分類（2025-2032）

• 市場概況
• 膠囊內視鏡
• 藥物輸送
• 病患監測
• 其他

全球智慧藥丸技術市場規模與複合年成長率：按最終用戶分類（2025-2032）

• 市場概況
• 醫院/診所
• 診斷中心
• 研究中心

全球智慧藥丸技術市場規模/複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• IntroMedic 有限公司（韓國）
• CapsoVision, Inc.（美國）
• Koninklijke Philips NV（荷蘭）
• 奧林巴斯公司（日本）
• RF株式會社（日本）
• 總部有限公司（美國）
• Proteus 數位健康（美國）
• 美敦力公司（愛爾蘭）
• 重慶金山科技(集團)有限公司 (中國)
• 檢查-Cap 有限公司（以色列）
• AnX Robotica Corp.（美國）
• 深圳市吉復醫療科技有限公司 (中國)
• etecRx（美國）
• BodyCap (France)
• 大塚美國製藥公司（美國）
• GE醫療集團（美國）
• 波士頓科學公司（美國）
• Give Imaging Ltd.（現為美敦力公司的一部分）（以色列）
• Bio-Images Research Limited（英國）
• Lucid 診斷（美國）

結論和建議

Global Smart Pills Technology Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.23 billion in 2024 to USD 8.13 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

Smart pills represent a significant advancement in digital health, characterized by their capsule-like design and advanced capabilities such as sensing, imaging, and targeted medication delivery. These innovative devices navigate the gastrointestinal tract to capture diagnostic images that were previously challenging to obtain, effectively serving as non-invasive alternatives to traditional methods like endoscopy. Smart pills often integrate with a wearable sensor patch that communicates with a provider portal and a mobile app, allowing healthcare professionals to closely monitor patient data. They facilitate diagnosis of gastrointestinal conditions, including gastroparesis and constipation, and enhance medication adherence. This system captures vital metrics like pulse rate, body temperature, and gastric pH, offering a comprehensive view of patient health and revolutionizing the approach to diagnosing and managing gastrointestinal disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segmental Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The global smart pills technology market is poised for substantial growth in the foreseeable future, primarily fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Lifestyle factors such as sedentary habits are also contributing to this rising demand, alongside enhanced patient compliance thanks to minimally invasive techniques associated with smart pills. Furthermore, the market is expected to benefit from the evolving health challenges linked to modern lifestyles. As disposable incomes rise in both developed and emerging markets, more individuals will have the financial means to invest in these innovative technologies. The aging population, particularly those susceptible to inflammatory bowel diseases like ulcerative colitis and Crohn's disease, will also serve as a significant driver for market expansion.

Restraints in the Global Smart Pills Technology Market

The Global Smart Pills Technology market faces several constraints that hinder its growth despite the numerous benefits offered by this innovative technology. Key challenges include the limited technological advancement of capsule endoscopes and patients' concerns regarding the ingestion of microchips. Moreover, the high prices associated with ingestible sensors, combined with stringent government regulations governing their usage, further restrict market expansion. In developing countries, inadequate reimbursement policies often result in insufficient patient coverage, exacerbating the issue. Additionally, the technological shortcomings of various smart pill applications impede their widespread adoption throughout the forecast period, posing significant barriers to market progress.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is experiencing significant growth, driven by the increasing demand for innovative, AI-IoT solutions like the Smart Pill Expert System (SPES). As healthcare systems face challenges such as Medical Non-Adherence (MNA), SPES provides a reliable platform for automating medication administration and enhancing patient monitoring in nursing homes, hospices, and home healthcare facilities. Its ability to serve multiple users simultaneously while maintaining a low failure rate underscores its potential to improve medication adherence and patient outcomes. Additionally, the integration of advanced chatbots for real-time health assessments further distinguishes SPES, positioning it as a frontrunner in the evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2025-2032)

• Market Overview
• Esophagus
• Stomach
• Small Intestine
• Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Barrett'S Esophagus
• Small Bowel Diseases
• Colon Cancer
• Others

Global Smart Pills Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring
• Others

Global Smart Pills Technology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centres
• Research Centres

Global Smart Pills Technology Market Size & CAGR (2025-2032)

• North America (Target Area, Disease Indication, Application, End User)
  • US
  • Canada
• Europe (Target Area, Disease Indication, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Target Area, Disease Indication, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Target Area, Disease Indication, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Target Area, Disease Indication, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IntroMedic Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapsoVision, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RF Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HQ, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Digital Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Check-Cap Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnX Robotica Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Jifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• etecRx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BodyCap (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka America Pharmaceutical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Given Imaging Ltd. (Now part of Medtronic) (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Images Research Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucid Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations